Deutsche Biotech Innovativ AG Logo

Deutsche Biotech Innovativ AG

ISIN: DE000A0Z25L1 | Ticker: DBI | LEI: 391200BIDNL2ZOKI1M61
Sector: Health CareSub-Industry: Biotechnology
Country: Germany

About Deutsche Biotech Innovativ AG

Company Description

Deutsche Biotech Innovativ (DBI) AG is a listed biotechnology company based in Hennigsdorf near Berlin.

The DBI share (DE000A0Z25L1) is traded over-the-counter on the Düsseldorf Stock Exchange. Since fall 2017, the DBI share has also been listed on the Frankfurt Stock Exchange and the Berlin Stock Exchange.

DBI AG was founded in 2009 as Venetus Beteiligungen AG. The company was renamed Deutsche Biotech Innovativ AG in August 2014.

DBI invests in biotechnology companies that pursue an innovative research and development approach and develop drug candidates with a high unique selling proposition.

Year founded

2009

Served area

Worldwide

Headquarters

Neuendorfstraße 15a, 16761 Hennigsdorf bei Berlin – Germany

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DE000A0Z25L1

LEI

391200BIDNL2ZOKI1M61

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.